Biocon Ltd. — Investor Relations & Filings
Biocon Ltd. is a global biopharmaceutical company focused on developing innovative therapies for chronic conditions such as diabetes, oncology, and autoimmune diseases. The company specializes in the research, development, and manufacture of high-quality biosimilars, generic active pharmaceutical ingredients (APIs), and novel biologics. Its portfolio includes recombinant human insulin, insulin analogs, and monoclonal antibodies. Biocon leverages an integrated business model encompassing advanced research and development, large-scale manufacturing, and global commercialization. By prioritizing affordable innovation, the company aims to enhance access to life-saving treatments across international markets, including the United States, Europe, and emerging economies. Its technical expertise in microbial fermentation and complex protein engineering supports a robust pipeline of complex therapeutics designed to address unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Copy of Newspaper Publication | 2026-05-09 | English | |
| Copy of Newspaper Publication | 2026-05-09 | English | |
| Newspaper Advertisement-Postal Ballot Notice | 2026-05-09 | English | |
| Newspaper Advertisement - Financial Results | 2026-05-09 | English | |
| Postal Ballot Notice | 2026-05-08 | English | |
| Shareholders meeting | 2026-05-08 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44648096 | Copy of Newspaper Publication | 2026-05-09 | English | ||
| 44648098 | Copy of Newspaper Publication | 2026-05-09 | English | ||
| 44723223 | Newspaper Advertisement-Postal Ballot Notice | 2026-05-09 | English | ||
| 44723224 | Newspaper Advertisement - Financial Results | 2026-05-09 | English | ||
| 44723225 | Postal Ballot Notice | 2026-05-08 | English | ||
| 44424232 | Shareholders meeting | 2026-05-08 | English | ||
| 44315704 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-08 | English | ||
| 44723226 | Audio and video recording of Q4 2026 | 2026-05-08 | English | ||
| 43955963 | Investor Presentation | 2026-05-08 | English | ||
| 44723230 | Investor Presentation | 2026-05-08 | English | ||
| 43390572 | Monitoring Agency Report | 2026-05-07 | English | ||
| 44723231 | Outcome of Board Meeting_Monitoring Agency Report | 2026-05-07 | English | ||
| 43348518 | Record Date | 2026-05-07 | English | ||
| 43348530 | Press Release | 2026-05-07 | English | ||
| 43348544 | Outcome of Board Meeting | 2026-05-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bora Pharmaceuticals Co., Ltd.
Global pharmaceutical provider of CDMO services and special…
|
6472 | TW | Manufacturing |
|
Boryung Corporation
A healthcare company developing pharmaceuticals and investi…
|
003850 | KR | Manufacturing |
|
Bosnalijek d.d. Sarajevo
Develops, manufactures, and exports a wide range of pharmac…
|
BSNL | BA | Manufacturing |
|
BOTANIX PHARMACEUTICALS LTD
Develops topical skin treatments using proprietary Permetre…
|
BOT | AU | Manufacturing |
|
Boule Diagnostics
Provider of hematology systems for decentralized human and …
|
BOUL | SE | Manufacturing |
|
Boundless Bio, Inc.
Clinical-stage oncology company targeting ecDNA in oncogene…
|
BOLD | US | Manufacturing |
|
Brandselite International Corporation
Marketer and distributor of branded consumer products, incl…
|
— | CA | Manufacturing |
|
Brawn Biotech Limited
Manufactures and exports WHO-GMP compliant generic medicine…
|
530207 | IN | Manufacturing |
|
Breath of Life International Ltd.
A prominent producer of medical cannabis products, engaged …
|
BOLP | CA | Manufacturing |
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
Biocon Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61176/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61176 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61176 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61176 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61176}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biocon Ltd. (id: 61176)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.